Researchers awarded 6.1 million euros to address female fertility problems

NewsGuard 100/100 Score

Queen's University have been awarded 6.1 million euros, in collaboration with 11 other global partner universities and institutions, to develop a test to identify harmful chemicals that affect female fertility.

The grant is part of a wider research project funded by the European Research and Innovation programme Horizon 2020 to develop highly needed test methods to identify harmful chemicals, known as endocrine disruptors. The tests will be used to address a range of health issues affecting humans, animals and the environment.

Endocrine disruptors are chemicals that can interfere with hormones and are found in everyday products such as plastics, air fresheners and cosmetics. Without dedicated tests to assess endocrine disruptor properties, it is difficult to gauge the damage these chemicals can have on humans, animals and the environment.

Better test methods will help protect the health of humans and the environment. In humans, endocrine disruptors can affect fertility and brain development. Animals can be affected by endocrine disruptors in the environment. For example, male fish are increasingly carrying female eggs caused by the release of endocrine disruptors released by waste water treatment plants.

Researchers at Queen's University and Vrije Universiteit, Netherlands have been awarded 6.1 million euros to develop a test on assess how endocrine disruptors can affect a women's fertility (through the FREIA project).

Dr Lisa Connolly from the Institute for Global Food Security at Queen's University, co-author on the study explained: "There is surprisingly limited knowledge on this issue. We will investigate how exposure to endocrine disruptors during different hormone-sensitive phases in a woman's life such as the fetal, puberty, and adult stages, can ultimately affect her fertility."

The main aim of this project is to develop tests for humans to identify the chemicals that can cause damage to the female reproductive system.

Dr Connolly added: "We are delighted to be part of this research project which brings together experts across a number of countries. It is only through developing a test to better understand how these chemicals affect fertility that we will then be in a position to offer solutions."



The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Vitrification technique leads to successful birth after ovarian tissue cryopreservation